These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16987664)

  • 21. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
    Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation.
    Jin HS; Lee DH; Kim DH; Chung JH; Lee SJ; Lee TH
    Cancer Res; 2009 Mar; 69(5):1782-91. PubMed ID: 19223549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Mabb AM; Wuerzberger-Davis SM; Miyamoto S
    Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.
    Calao M; Burny A; Quivy V; Dekoninck A; Van Lint C
    Trends Biochem Sci; 2008 Jul; 33(7):339-49. PubMed ID: 18585916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Phosphorylations of IKKγ/NEMO.
    Lee SH; Toth Z; Wong LY; Brulois K; Nguyen J; Lee JY; Zandi E; Jung JU
    mBio; 2012 Nov; 3(6):e00411-12. PubMed ID: 23131831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
    Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
    Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.
    Rushe M; Silvian L; Bixler S; Chen LL; Cheung A; Bowes S; Cuervo H; Berkowitz S; Zheng T; Guckian K; Pellegrini M; Lugovskoy A
    Structure; 2008 May; 16(5):798-808. PubMed ID: 18462684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NEMO shuttle: a link between DNA damage and NF-kappaB activation in progeroid syndromes?
    Salminen A; Suuronen T; Huuskonen J; Kaarniranta K
    Biochem Biophys Res Commun; 2008 Mar; 367(4):715-8. PubMed ID: 18201555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation.
    Kovalenko A; Wallach D
    Mol Cell; 2006 May; 22(4):433-6. PubMed ID: 16713572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of NF-kB in multiple myeloma: therapeutic implications.
    Feinman R; Siegel DS; Berenson J
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):162-6. PubMed ID: 16166946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEMO binding domain of IKK-2 encompasses amino acids 735-745.
    Strnad J; McDonnell PA; Riexinger DJ; Mapelli C; Cheng L; Gray H; Ryseck RP; Burke JR
    J Mol Recognit; 2006; 19(3):227-33. PubMed ID: 16583354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in NF-kappaB signaling transduction and transcription.
    Xiao W
    Cell Mol Immunol; 2004 Dec; 1(6):425-35. PubMed ID: 16293211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB oscillations and cell-to-cell variability.
    Hayot F; Jayaprakash C
    J Theor Biol; 2006 Jun; 240(4):583-91. PubMed ID: 16337239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.
    Berchtold CM; Wu ZH; Huang TT; Miyamoto S
    Mol Cell Biol; 2007 Jan; 27(2):497-509. PubMed ID: 17074802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.
    Gotoh Y; Nagata H; Kase H; Shimonishi M; Ido M
    Anal Biochem; 2010 Oct; 405(1):19-27. PubMed ID: 20522330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-kappaB activation by double-strand breaks.
    Habraken Y; Piette J
    Biochem Pharmacol; 2006 Oct; 72(9):1132-41. PubMed ID: 16965765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.